Clinical trial
A Post-Market Study in Japan for the Evaluation of the CorPath® GRX System Effectiveness in Percutaneous Coronary Interventions
NCT03870087 is registered in ClinicalTrials.gov with Siemens Healthineers Endovascular Robotics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Market Study in Japan for the Evaluation of the CorPath® GRX System Effectiveness in Percutaneous Coronary Interventions
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2019
- Completion date
- October 9, 2020
- Enrollment
- 242 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.